Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pialoux

Showing results (401-410 of 421) with videos related to

Pageof 43
Sort By:
AIDS (London, England)|May 4, 2021
Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1Peter Ackerman, Melanie Thompson, Jean-Michel Molina, et al.
NPJ Vaccines|June 25, 2019
HIV therapeutic vaccine enhances non-exhausted CD4<sup>+</sup> T cells in a randomised phase 2 trialVincent Vieillard, Béhazine Combadière, Roland Tubiana, et al.
Pediatric Blood & Cancer|January 19, 2017
Alpha-thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changesCéline Renoux, Philippe Connes, Elie Nader, et al.
AIDS (London, England)|June 18, 2025
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the prerandomisation phase of a clinical trialKris Hage, Anders Boyd, Udi Davidovich, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 15, 2024
High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022Romain Palich, Andrés Arias-Rodríguez, Martin Duracinsky, et al.
Lancet Regional Health. Americas|October 9, 2024
Micro- and macrovascular function in the highest city in the world: a cross sectional studyYann Savina, Aurélien P Pichon, Lucas Lemaire, et al.
The Lancet. HIV|October 31, 2020
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE studyMax Lataillade, Jacob P Lalezari, Michael Kozal, et al.
The Lancet. HIV|June 30, 2022
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort studyJean-Michel Molina, Jade Ghosn, Lambert Assoumou, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 8, 2022
Differential effects of high-altitude exposure on markers of oxidative stress, antioxidant capacity, and iron profilesChantal L Rytz, Matiram Pun, Jamie A Mawhinney, et al.
The Lancet. HIV|July 28, 2017
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort studyJean-Michel Molina, Isabelle Charreau, Bruno Spire, et al.
Pageof 43

Showing results (401-410 of 421) with videos related to

Sort By:
Pageof 43
AIDS (London, England)|May 4, 2021
Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1Peter Ackerman, Melanie Thompson, Jean-Michel Molina, et al.
NPJ Vaccines|June 25, 2019
HIV therapeutic vaccine enhances non-exhausted CD4<sup>+</sup> T cells in a randomised phase 2 trialVincent Vieillard, Béhazine Combadière, Roland Tubiana, et al.
Pediatric Blood & Cancer|January 19, 2017
Alpha-thalassaemia promotes frequent vaso-occlusive crises in children with sickle cell anaemia through haemorheological changesCéline Renoux, Philippe Connes, Elie Nader, et al.
AIDS (London, England)|June 18, 2025
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the prerandomisation phase of a clinical trialKris Hage, Anders Boyd, Udi Davidovich, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 15, 2024
High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022Romain Palich, Andrés Arias-Rodríguez, Martin Duracinsky, et al.
Lancet Regional Health. Americas|October 9, 2024
Micro- and macrovascular function in the highest city in the world: a cross sectional studyYann Savina, Aurélien P Pichon, Lucas Lemaire, et al.
The Lancet. HIV|October 31, 2020
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE studyMax Lataillade, Jacob P Lalezari, Michael Kozal, et al.
The Lancet. HIV|June 30, 2022
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort studyJean-Michel Molina, Jade Ghosn, Lambert Assoumou, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 8, 2022
Differential effects of high-altitude exposure on markers of oxidative stress, antioxidant capacity, and iron profilesChantal L Rytz, Matiram Pun, Jamie A Mawhinney, et al.
The Lancet. HIV|July 28, 2017
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort studyJean-Michel Molina, Isabelle Charreau, Bruno Spire, et al.
Pageof 43